TENAX THERAPEUTICS, INC. Income Taxes Paid
TENAX THERAPEUTICS, INC. (TENX) reported Income Taxes Paid of $27.53 thousand for the 557-month period ending 2014-01-31, per its 10-Q filed 2014-03-17.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2014-03-17
- TENAX THERAPEUTICS, INC. income taxes paid for the quarter ending 2014-01-31 was $0.00.
- TENAX THERAPEUTICS, INC. income taxes paid for the quarter ending 2013-01-31 was $0.00.
- TENAX THERAPEUTICS, INC. income taxes paid for the quarter ending 2012-04-30 was $0.00.
- TENAX THERAPEUTICS, INC. income taxes paid for the quarter ending 2012-01-31 was $0.00.
- TENAX THERAPEUTICS, INC. income taxes paid for fiscal 2012 was $0.00.
- TENAX THERAPEUTICS, INC. income taxes paid for fiscal 2011 was $0.00.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month | Income Taxes Paid 530 month | Income Taxes Paid 533 month | Income Taxes Paid 536 month | Income Taxes Paid 539 month | Income Taxes Paid 542 month | Income Taxes Paid 545 month | Income Taxes Paid 554 month | Income Taxes Paid 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $27.53K 10-Q · filed 2014-03-17 | |||||||||
| 2013-10-31 | $0.00 10-Q · filed 2013-12-17 | $27.53K 10-Q · filed 2013-12-17 | ||||||||||
| 2013-07-31 | $27.53K 10-Q · filed 2013-09-17 | |||||||||||
| 2013-04-30 | $27.53K 10-K · filed 2013-06-26 | |||||||||||
| 2013-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $27.53K 10-Q · filed 2013-03-18 | |||||||||
| 2012-10-31 | $0.00 10-Q · filed 2013-12-17 | $27.53K 10-Q · filed 2012-12-14 | ||||||||||
| 2012-07-31 | $27.53K 10-Q · filed 2012-09-19 | |||||||||||
| 2012-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $0.00 derived: sum of 2 quarters · filed 2012-07-25 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 10-K · filed 2012-07-25 | $27.53K 10-K · filed 2012-07-25 | |||||||
| 2012-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $0.00 10-Q · filed 2012-03-15 | $0.00 derived: sum of 4 quarters · filed 2012-07-25 | $27.53K 10-Q · filed 2012-03-15 | |||||||
| 2011-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-15 | $0.00 10-Q · filed 2011-12-15 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 derived: sum of 4 quarters · filed 2012-07-25 | $27.53K 10-Q · filed 2011-12-15 | |||||||
| 2011-07-31 | $0.00 10-Q · filed 2011-09-19 | $0.00 derived: sum of 2 quarters · filed 2012-07-25 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 derived: sum of 4 quarters · filed 2012-07-25 | $27.53K 10-Q · filed 2011-09-19 | |||||||
| 2011-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $0.00 derived: sum of 2 quarters · filed 2012-07-25 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 10-K · filed 2012-07-25 | ||||||||
| 2011-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $0.00 10-Q · filed 2012-03-15 | |||||||||
| 2010-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-15 | $0.00 10-Q · filed 2011-12-15 | ||||||||||
| 2010-07-31 | $0.00 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |